Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATNM Actinium Pharmaceuticals, Inc.

盘前交易 11-22 08:10:57 EST

1.47

+0.08

+5.76%

最高1.47	最低1.37	成交量27.78万
今开1.41	昨收1.39	日振幅7.55%
总市值4,586万	流通市值4,563万	总股本3,120万
成交额39.45万	换手率0.90%	流通股本3,104万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals, Inc.","latestPrice":1.47,"timestamp":1732222800000,"preClose":1.39,"halted":0,"volume":277822,"delay":0,"floatShares":31037749,"shares":31195891,"eps":-1.404755,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.08,"latestTime":"11-22 08:10:57 EST","open":1.41,"high":1.47,"low":1.365,"amount":394463.7330748,"amplitude":0.07554,"askPrice":1.58,"askSize":100,"bidPrice":1.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.404755,"exchange":"AMEX","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"adjPreClose":1.47,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.47,"latestTime":"19:19 EST","volume":1196,"amount":1756.76,"timestamp":1732234758920},"volumeRatio":0.7566372668717942,"impliedVol":0.5223,"impliedVolPercentile":0.0478},"requestUrl":"/m/hq/s/ATNM","defaultTab":"news","newsList":[{"id":"2484751296","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨8.63%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484751296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484751296?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940317,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速拉升8.63%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.29%、191.91%、184.79%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为40.36%、31.28%、19.34%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822315798e433b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822315798e433b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2483605117","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速下挫5.18%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483605117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483605117?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:45","pubTimestamp":1731444326,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时45分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.18%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为1.09%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113044526a2316610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113044526a2316610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2481167640","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481167640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481167640?lang=zh_cn&edition=full","pubTime":"2024-11-08 04:51","pubTimestamp":1731012681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日04时51分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下挫5.18%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.18%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108045121abab2150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108045121abab2150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2480853397","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480853397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480853397?lang=zh_cn&edition=full","pubTime":"2024-11-02 02:06","pubTimestamp":1730484377,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日02时06分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速下挫5.00%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.39%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102020618971a3eb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102020618971a3eb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2479337751","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479337751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479337751?lang=zh_cn&edition=full","pubTime":"2024-10-31 03:23","pubTimestamp":1730316206,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日03时23分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.05%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为5217.59%、3110.08%、434.72%，振幅较大的相关个股有Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.，振幅分别为146.80%、91.64%、77.90%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103103232698e3f7c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103103232698e3f7c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2478669267","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大跌5.00%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478669267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478669267?lang=zh_cn&edition=full","pubTime":"2024-10-25 02:29","pubTimestamp":1729794541,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日02时29分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.00%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Monopar Therapeutics Inc.、Quince Therapeutics, Inc.、Aligos Therapeutics, Inc.涨幅较大，Monopar Therapeutics Inc.、Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为344.86%、285.99%、201.00%，振幅较大的相关个股有Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.，振幅分别为679.91%、78.77%、71.78%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102502290198e3e4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102502290198e3e4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2477364640","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘急速拉升5.06%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477364640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477364640?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:50","pubTimestamp":1729623058,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时50分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅上涨5.06%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5635.88%、5032.25%、2163.49%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023025058971a1a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023025058971a1a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2476213249","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅拉升5.69%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476213249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476213249?lang=zh_cn&edition=full","pubTime":"2024-10-19 03:41","pubTimestamp":1729280474,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日03时41分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速拉升5.69%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1629.17%、1006.50%、646.62%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为255.36%、152.68%、113.50%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019034114ab6b3882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019034114ab6b3882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2474277295","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474277295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474277295?lang=zh_cn&edition=full","pubTime":"2024-10-10 02:16","pubTimestamp":1728497776,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日02时16分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下跌5.52%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.01%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002161698e3b855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002161698e3b855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2473876844","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473876844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473876844?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:47","pubTimestamp":1728326831,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时47分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅下挫5.03%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1650.89%、88.64%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Akari Therapeutics Plc，振幅分别为107.82%、39.46%、37.93%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080247119719eb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080247119719eb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2472335775","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速上涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472335775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472335775?lang=zh_cn&edition=full","pubTime":"2024-10-01 00:27","pubTimestamp":1727713639,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日00时27分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.28%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.38%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001002719ab672e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001002719ab672e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2469676714","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469676714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469676714?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:29","pubTimestamp":1726849771,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时29分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.32%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Galmed Pharmaceuticals Ltd.、Novabay Pharmaceuticals, Inc.、Corbus Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为2063.40%、2060.36%、73.05%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Apollomics Inc C/Wts 01/04/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为165.20%、71.11%、68.42%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210029319719c0c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210029319719c0c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2468508603","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508603?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:08","pubTimestamp":1726754937,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时08分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅上涨5.06%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为2761.06%、553.60%、137.87%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为81.66%、76.38%、52.97%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220857a1db335f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220857a1db335f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2462998943","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速上涨5.47%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462998943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462998943?lang=zh_cn&edition=full","pubTime":"2024-08-27 00:11","pubTimestamp":1724688715,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日00时11分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速上涨5.47%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Bright Minds Biosciences Inc.、Silexion Therapeutics Corp涨幅较大，Tonix Pharmaceuticals Holding Corp.、Elevai Labs, Inc.、Scisparc Ltd.较为活跃，换手率分别为409.10%、177.52%、116.34%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为61.39%、50.34%、49.09%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270011559719a0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270011559719a0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2460042570","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.26%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460042570","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460042570?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:35","pubTimestamp":1724160949,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时35分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升5.26%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为1814.72%、335.65%、191.63%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药，振幅分别为103.11%、78.89%、28.68%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213549971994bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213549971994bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2459701154","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速上涨6.96%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459701154","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459701154?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:32","pubTimestamp":1723739575,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日00时32分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升6.96%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.48%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816003256a1d47642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816003256a1d47642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2459849824","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅下跌5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459849824","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459849824?lang=zh_cn&edition=full","pubTime":"2024-08-15 03:25","pubTimestamp":1723663559,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日03时25分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.00%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.06%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032559ab5db21b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032559ab5db21b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2458981999","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅下挫5.37%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458981999","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458981999?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:09","pubTimestamp":1723471743,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时09分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速跳水5.37%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为311.69%、59.33%、35.11%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为91.10%、40.71%、39.67%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220904aefe6c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220904aefe6c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2458990595","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速下跌5.81%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458990595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458990595?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:30","pubTimestamp":1723210206,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时30分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.81%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为3.86%。其相关个股中，Mesoblast Ltd、Spero Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为30.22%、5.01%、3.59%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213006941ffbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213006941ffbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2457316259","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.14%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457316259","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457316259?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:31","pubTimestamp":1723123917,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时31分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速拉升5.14%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Anew Medical, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为177.66%、172.25%、38.59%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为25.33%、15.60%、13.96%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213157941ff724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213157941ff724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actiniumpharma.com","stockEarnings":[{"period":"1week","weight":-0.1091},{"period":"1month","weight":-0.2181},{"period":"3month","weight":-0.2687},{"period":"6month","weight":-0.8271},{"period":"1year","weight":-0.6674},{"period":"ytd","weight":-0.7106}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actinium Pharmaceuticals, Inc.于1997年10月6日在内华达州注册成立。该公司曾是一家空壳公司，在市场上与合适的经营公司合并。该公司现在是一家生物制药公司，专注于抗癌药物的540亿美元的市场。该公司最先进的产品是Actimab -A ，含有AC-225抗体药物结构，目前在急性髓系白血病（AML）和Iomab-B——一种包含iodine131的抗体药物结构进行人体临床试验，用于造血干细胞移植时使用。该公司目前正在设计并申请一项造血干细胞移植的试验，主要针对老年患者难治的复发性急性髓系白血病。该公司正在利用其在放射免疫治疗领域的专业知识开发治疗癌症的药物。此外， AC-225为基础的药物开发依赖于专利的α粒子免疫治疗技术（ APIT ）平台，这是与Memorial Sloan Kettering癌症中心合作开发的技术，该中心的间接附属公司Actinium Holdings有限责任公司是制药公司的大股东。APIT技术与单克隆抗体结合时非常有效，但相对安全的α粒子会发射放射性同位素，尤其是锕225和铋213 ，最终药物结构的设计是专门针对并且杀死癌细胞，同时尽量减少副作用。该公司拟开发不同类型的癌症治疗产品，从与大型制药公司的合作和直接在专业市场销售其产品获得收益。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.050048},{"month":2,"riseRate":0.4,"avgChangeRate":-0.009843},{"month":3,"riseRate":0.1,"avgChangeRate":-0.087476},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.045042},{"month":5,"riseRate":0.727273,"avgChangeRate":0.084309},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.022588},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.031624},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.113388},{"month":9,"riseRate":0.454545,"avgChangeRate":0.034022},{"month":10,"riseRate":0.545455,"avgChangeRate":0.061839},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.051003},{"month":12,"riseRate":0.3,"avgChangeRate":-0.055118}],"exchange":"AMEX","name":"Actinium Pharmaceuticals, Inc.","nameEN":"Actinium Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actinium Pharmaceuticals, Inc.,ATNM,Actinium Pharmaceuticals, Inc.股票,Actinium Pharmaceuticals, Inc.股票老虎,Actinium Pharmaceuticals, Inc.股票老虎国际,Actinium Pharmaceuticals, Inc.行情,Actinium Pharmaceuticals, Inc.股票行情,Actinium Pharmaceuticals, Inc.股价,Actinium Pharmaceuticals, Inc.股市,Actinium Pharmaceuticals, Inc.股票价格,Actinium Pharmaceuticals, Inc.股票交易,Actinium Pharmaceuticals, Inc.股票购买,Actinium Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}